Reclassifying bronchial-pulmonary carcinoma: differentiating histological type in biopsies by immunohistochemistry (Q37622073)

21 August 2017

1 reference

title

Reclassifying bronchial-pulmonary carcinoma: differentiating histological type in biopsies by immunohistochemistry (English)

1 reference

21 August 2017

0 references

1 reference

Lina Carvalho

1

0 references

publication date

1 November 2009

1 reference

Revista portuguesa de pneumologia

21 August 2017

published in

1 reference

21 August 2017

volume

15

1 reference

21 August 2017

issue

6

1 reference

21 August 2017

page(s)

1101-1119

1 reference

describes a project that uses

21 August 2017

1 reference

The World Health Organization histological typing of lung tumours. Second edition

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

The impact of cigarette smoking on prognosis in small adenocarcinomas of the lung: the association between histologic subtype and smoking status

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

The IASLC lung cancer staging project. Comparing the current 6(th) TNM edition with the proposed 7(th) edition

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Class III -Tubulin Expression and Benefit from Adjuvant Cisplatin/Vinorelbine Chemotherapy in Operable Non-Small Cell Lung Cancer: Analysis of NCIC JBR.10

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Class III beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Thyroid transcription factor-1 (TTF-1/Nkx2.1/TITF1) gene regulation in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Pathologist and molecular biologist, ever the twain shall meet?

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

TGT3, thyroid transcription factor I, and Sp1 elements regulate transcriptional activity of the 1.3-kilobase pair promoter of T1alpha, a lung alveolar type I cell gene

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Correlation between morphology and EGFR mutations in lung adenocarcinomas Significance of the micropapillary pattern and the hobnail cell type

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Thyroglobulin repression of thyroid transcription factor 1 (TTF-1) gene expression is mediated by decreased DNA binding of nuclear factor I proteins which control constitutive TTF-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Bronchiolar columnar cell dysplasia--genetic analysis of a novel preneoplastic lesion of peripheral lung

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Small adenocarcinoma of the lung. Histologic characteristics and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

True papillary carcinoma of the lung: a distinct clinicopathologic entity

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Reproducibility of the diagnosis of small adenocarcinoma of the lung and usefulness of an educational program for the diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Immunohistochemically detected micrometastases in peribronchial and mediastinal lymph nodes from patients with T1, N0, M0 pulmonary adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Mesothelioma treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

DNA methylation markers and early recurrence in stage I lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Problems in mesothelioma diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy With Uracil-Tegafur for Adenocarcinoma of the Lung

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Neuroendocrine carcinomas of the lung: a critical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Genetics of a combined lung small cell carcinoma and large cell neuroendocrine carcinoma with adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Combined small cell lung carcinomas: genotypic and immunophenotypic analysis of the separate morphologic components

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchial carcinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Results of systematic nodal dissection in typical and atypical carcinoid tumors of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Thyroid transcription factor 1: a marker for lung adenoarinoma in body cavity fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

The Synergistic Activity of Thyroid Transcription Factor 1 and Pax 8 Relies on the Promoter/Enhancer Interplay

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

How could pharmacogenomics help improve patient survival?

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

The challenge of classifying poorly differentiated tumours in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC).

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Lung cancer treatment - Biology based decision, from gene to histology

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Pemetrexed in second line of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Pulmonary adenocarcinoma: review of 106 cases and proposed new classification

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents?

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Molecular signatures of lung cancer--toward personalized therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Prospective Study of Gefitinib in Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization–Positive/Phospho-Akt–Positive or Never Smoker Patients With Advanced Non–Small-Cell Lung Cancer: The ONCOBELL Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

1 reference

7 January 2021

Detection of mutations in EGFR in circulating lung-cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Three-Gene Prognostic Classifier for Early-Stage Non–Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

DNA repair and survival in lung cancer--the two faces of Janus

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Increased telomerase activity and comprehensive lifestyle changes: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Small cluster invasion: a possible link between micropapillary pattern and lymph node metastasis in pT1 lung adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0873-2159%2815%2930195-1

7 January 2021

10.1016/S0873-2159(15)30195-1

Identifiers

DOI

1 reference

21 August 2017

1 reference